Chronic Lymphocytic Leukemia

About
Mappings

NCI Thesaurus: Chronic Lymphocytic Leukemia (coding:ncit:C3163)

OncoTree: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (coding:oncotree:CLLSLL)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Organizations Biomarkers Cancer types Therapies
FDA (1) CD20 + Chronic Lymphocytic Leukemia Cyclophosphamide, Fludarabine, Rituximab
EMA (1) HSE (1) TP53 Somatic variants Chronic Lymphocytic Leukemia Venetoclax
EMA (1) HSE (1) TP53 deletion Chronic Lymphocytic Leukemia Venetoclax
EMA (2) HSE (2) not 17p deletion Chronic Lymphocytic Leukemia Venetoclax
EMA (1) HSE (1) Wild type TP53 Chronic Lymphocytic Leukemia Venetoclax
EMA (1) HSE (1) TP53 deletion Chronic Lymphocytic Leukemia Idelalisib, Rituximab
EMA (1) HSE (1) TP53 Somatic variants Chronic Lymphocytic Leukemia Idelalisib, Rituximab
EMA (1) HSE (1) not 17p deletion Chronic Lymphocytic Leukemia Idelalisib, Rituximab
HSE (1) TP53 Somatic variants Chronic Lymphocytic Leukemia Zanubrutinib
HSE (1) TP53 deletion Chronic Lymphocytic Leukemia Zanubrutinib
HSE (1) not 17p deletion Chronic Lymphocytic Leukemia Zanubrutinib
HSE (1) TP53 Somatic variants Chronic Lymphocytic Leukemia Acalabrutinib
HSE (1) TP53 deletion Chronic Lymphocytic Leukemia Acalabrutinib
HSE (1) not 17p deletion Chronic Lymphocytic Leukemia Acalabrutinib
HSE (1) TP53 Somatic variants Chronic Lymphocytic Leukemia Ibrutinib
HSE (1) TP53 deletion Chronic Lymphocytic Leukemia Ibrutinib
FDA (1) HSE (1) not 17p deletion Chronic Lymphocytic Leukemia Ibrutinib